Jayxime 200 DT Tablet contains Cefixime 200mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefixime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This medication is indicated for the treatment of infections caused by susceptible strains of bacteria, including uncomplicated urinary tract infections, acute otitis media, pharyngitis, tonsillitis, bronchitis, and certain sexually transmitted infections such as uncomplicated gonorrhea. Jayxime 200 DT is formulated as a dispersible tablet, facilitating ease of administration, particularly in patients with swallowing difficulties. The drug is well absorbed orally, with peak plasma concentrations typically achieved within 2 to 6 hours post-administration. Dosage and duration of therapy should be determined based on the severity and type of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions in susceptible individuals. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Jayxime 200 DT should be used under medical supervision, ensuring appropriate use to minimize the risk of resistance development.